Actelion becomes latest recruit to join PatientsLikeMe
August 6, 2014Medical Communications, Research and Development, Sales and Marketing Actelion, PatientsLikeMe, digital
PatientsLikeMe and Actelion have come together in order to help create a new patient-reported outcomes tool for the rare form …
Liberation Communications promotes two
August 6, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Liberation Communications
Liberation Communications has made two promotions this August: Danielle Smith (right), has been promoted to account director whilst Vicky Smith …
Precious Cells Group appoints NHS stem cell expert
August 6, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Stem cells
Precious Cells Group, a UK-based provider of stem cell technologies including Biobanking services, has appointed Dr Salmaan Dalvi as its …
Roche gains new licence for blockbuster oncology drug
August 6, 2014Research and Development, Sales and Marketing EC, Roche, avastin, ovarian cancer
Roche’s blockbuster cancer treatment Avastin now has a new European licence to treat women with a certain type of ovarian …
Pradaxa ‘safe’ says Australian regulator
August 6, 2014Research and Development, Sales and Marketing AF, Australia, BMJ, Pradaxa, stroke
Australia’s drug regulator says it will not be updating its safety advice for Boehringer’s Pradaxa despite mounting safety issues around …
Novartis must drop vaccine price, says UK govt
August 5, 2014Medical Communications, Sales and Marketing Bexsero, Novartis, innoculation, meningococcal vaccine
Novartis will have to significantly lower the price of its meningococcal B vaccine if it wants a lucrative UK inoculation …
Blood cancer injection given green light
August 5, 2014Research and Development, Sales and Marketing MabThera, Roche, follicular lymphoma and small lymphocytic lymphoma
Roche has launched a new injection formulation of its blood cancer drug MabThera (rituximab) to treat patients with follicular lymphoma, …
Gene silencing back on the books for Roche
August 5, 2014Research and Development, Sales and Marketing RNA, Roche, Santaris, gene silencing
Roche will pay $450 million to acquire the RNA specialist firm Santaris Pharma in order to once again begin research …
Astellas hires Moyra Knight as head of comms
August 4, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Astellas has appointed industry veteran Moyra Knight as its new head of corporate and employee communications in the Americas region. …
PM Society announces Digital Media Awards finalists
August 4, 2014Medical Communications, Research and Development, Sales and Marketing awards, digital, pm society
The finalists for the 2014 PM Society digital media awards have been announced as pharma and med comms agencies get …
ABPI president: NICE needs political reform
August 1, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, NICE, Pfizer, jonathan emms, vba
Jonathan Emms, the new president of the ABPI, is a man not shy about defending the rights of the UK …
Minister calls for end of animal testing
August 1, 2014Research and Development, Sales and Marketing Animal testing
British MP Norman Baker has called for an end to all animal testing in the UK and promised to increase …
Genomes Project gains £300m UK funding boost
August 1, 2014Medical Communications, Research and Development, Sales and Marketing Genomics england, Illumina, NHS England, david cameron, genomes
A new funding stream aimed at helping British scientists map human DNA code will ‘revolutionise medicine’, according to prime minister …
Boehringer’s Striverdi gains FDA approval
August 1, 2014Sales and Marketing Advair, COPD, Pfizer, Spiriva, asthma, olodaterol
Boehringer Ingelheim’s new lung drug Striverdi has gained US approval for patients with chronic obstructive pulmonary disorder. Striverdi Respimat (olodaterol), …
AstraZeneca’s second quarter beats estimates
July 31, 2014Research and Development, Sales and Marketing AstraZeneca, Nexium, Pfizer
AstraZeneca posted a set of healthy financial results today as key platforms performed well for the company. Revenue in the …
‘Smart pill’ creator gains new funding
July 31, 2014Medical Communications, Research and Development, Sales and Marketing digital medicine, proteus, smart pills
Proteus Digital Health has raised $172 million to help develop its new brand of smart pills that can help patients …
Cause of rare childhood cancer discovered
July 31, 2014Research and Development, Sales and Marketing Cancer, RMS, YAP, childhood cancer
Scientists have made a breakthrough in understanding the cause of a rare childhood muscle cancer, called Rhabdomyosarcoma (RMS). Around 60 …
Tonic expands leadership team with two new hires
July 31, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Tonic Life Communications, the PR arm for Huntsworth Health, has added Tracey Carey as its new head of consumer and …
NICE won’t back Revlimid in new setting
July 31, 2014Medical Communications, Sales and Marketing Celgene, NICE, Revlimid, Thalidomide, multiple myeloma
NICE has once again said it does not think that Celgene’s rare cancer drug Revlimid should be used on the …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
